Bentham Science Logo

Clinical Cancer Drugs

Volume 6, 2 Issues, 2019
ISSN: 2212-6988 (Online)
ISSN: 2212-697X (Print)
This journal supports open access


Clinical Cancer Drugs, Volume 3 - Number 1

Prostate Cancer Molecular Background: The IGF-1Ec Story

, 3(1): 6 - 15

Armakolas Athanasios and Koutsilieris Michael

DOI: 10.2174/2212697X03666151203202720

Castration-resistant Prostate Cancer: The Targeting of Bone Microenvironment-related Survival Factors For Prostate Cancer Cells

, 3(1): 16 - 22

Dimitrios Karamanolakis, Athanasios Armakolas and Michael Koutsilieris

DOI: 10.2174/2212697X03666151203202934

Targeting Epigenome As An Innovative Pharmacological Strategy For Castration-resistant Prostate Cancer

, 3(1): 23 - 35

Lavinia Casati, Fabio Celotti and Valeria Sibilia

DOI: 10.2174/2212697X03666151207185452

Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy

, 3(1): 36 - 62

Festuccia Claudio

DOI: 10.2174/2212697X0301160328201324

Medicinal Compound Celastrol As a Potential Clinical Anticancer Drug: Lessons Learned From Preclinical Studies

, 3(1): 63 - 73

Jianquan Wu, Chengcheng Hong, Hongjie Pan, Qingzhu Yang, Yu Mei, Q. Ping Dou and Huanjie Yang

DOI: 10.2174/2212697X03666160112001739

Related Journals

Related eBooks

eBooks Catalog